You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review
|
|---|---|
| Published in |
Frontiers in oncology, May 2022
|
| DOI | 10.3389/fonc.2022.891580 |
| Pubmed ID | |
| Authors |
Gian Luca Rampioni Vinciguerra, Maura Sonego, Ilenia Segatto, Alessandra Dall’Acqua, Andrea Vecchione, Gustavo Baldassarre, Barbara Belletti |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 39 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 4 | 10% |
| Researcher | 4 | 10% |
| Student > Ph. D. Student | 4 | 10% |
| Other | 2 | 5% |
| Student > Doctoral Student | 2 | 5% |
| Other | 4 | 10% |
| Unknown | 19 | 49% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 7 | 18% |
| Agricultural and Biological Sciences | 6 | 15% |
| Medicine and Dentistry | 3 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Immunology and Microbiology | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 19 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2024.
All research outputs
#8,076,365
of 26,169,168 outputs
Outputs from Frontiers in oncology
#2,839
of 22,913 outputs
Outputs of similar age
#147,713
of 447,815 outputs
Outputs of similar age from Frontiers in oncology
#165
of 1,611 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,815 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 1,611 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.